Brenda Y. Hernandez to Papillomavirus Vaccines
This is a "connection" page, showing publications Brenda Y. Hernandez has written about Papillomavirus Vaccines.
Connection Strength
1.391
-
Tom A, Robinett H, Buenconsejo-Lum L, Soon R, Hamilton M, Francisco-Natanauan P, Cruz MR, Balajadia R, Hernandez BY. Promoting and Providing HPV Vaccination in Hawaii: Barriers Faced by Health Providers. J Community Health. 2016 10; 41(5):1069-77.
Score: 0.497
-
Hernandez BY, Wilkens LR, Thompson PJ, Shvetsov YB, Goodman MT, Ning L, Kaopua L. Acceptability of prophylactic human papillomavirus vaccination among adult men. Hum Vaccin. 2010 Jun; 6(6):467-75.
Score: 0.320
-
Hernandez BY. Prophylactic HPV vaccination for the prevention of cervical cancer. Hawaii Med J. 2007 Jul; 66(7):190-1.
Score: 0.262
-
Mix JM, Saraiya M, Thompson TD, Querec TD, Greek A, Tucker TC, Peters ES, Lynch CF, Hernandez BY, Copeland G, Goodman MT, Unger ER. Prevalence of human papillomavirus genotypes in high-grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States. Cancer. 2021 10 01; 127(19):3614-3621.
Score: 0.173
-
Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015 Jun; 107(6):djv086.
Score: 0.113
-
Steinau M, Saraiya M, Goodman MT, Peters ES, Watson M, Cleveland JL, Lynch CF, Wilkinson EJ, Hernandez BY, Copeland G, Saber MS, Hopenhayn C, Huang Y, Cozen W, Lyu C, Unger ER. Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerg Infect Dis. 2014 May; 20(5):822-8.
Score: 0.026